Overall, a sequential VEGF/VEGFR2/mTOR/Akt activation loop is conceivable in PAD models, with transplanted mADSCs serving to amplify the loop to facilitate angiogenesis. This evidence concerns the gene VEGFA and peripheral arterial disease.